This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Kang Li
Introduction
Kang Li is a notable inventor based in Richardson, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work is recognized for its potential impact on medical treatments and research.
Latest Patents
Kang Li holds a patent for "Anti Notch-1 antibodies." This invention is directed toward monoclonal antibodies that bind specifically to Notch1. In one embodiment, the antibodies bind to at least a first epitope and a second epitope, wherein the first epitope resides within the LinA domain of the Notch1 negative regulatory region (NRR), and the second epitope resides within the HD-C domain of the Notch1 NRR. He has 1 patent to his name.
Career Highlights
Kang Li is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to work on cutting-edge research and development projects that aim to improve healthcare outcomes.
Collaborations
Some of his notable coworkers include Ping Wei and Qinghai Peng. Their collaboration contributes to the innovative environment at Pfizer, fostering advancements in biotechnology.
Conclusion
Kang Li's work in developing Anti Notch-1 antibodies exemplifies the innovative spirit of modern biotechnology. His contributions are paving the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile